Brokerages expect that Envision Healthcare Co. (NYSE:EVHC) will post $1.97 billion in sales for the current quarter, according to Zacks. Six analysts have provided estimates for Envision Healthcare’s earnings, with the lowest sales estimate coming in at $1.94 billion and the highest estimate coming in at $2.02 billion. Envision Healthcare posted sales of $1.39 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 41.7%. The firm is expected to issue its next earnings results after the market closes on Tuesday, February 27th.
On average, analysts expect that Envision Healthcare will report full-year sales of $1.97 billion for the current year, with estimates ranging from $7.76 billion to $7.83 billion. For the next fiscal year, analysts anticipate that the company will post sales of $8.33 billion per share, with estimates ranging from $8.11 billion to $8.46 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research analysts that cover Envision Healthcare.
A number of equities analysts have recently commented on EVHC shares. KeyCorp set a $40.00 price target on shares of Envision Healthcare and gave the stock a “buy” rating in a report on Tuesday, November 14th. Jefferies Group set a $71.00 price target on shares of Envision Healthcare and gave the stock a “buy” rating in a report on Wednesday, November 1st. Robert W. Baird reiterated a “buy” rating and set a $70.00 price target on shares of Envision Healthcare in a report on Tuesday, October 17th. Canaccord Genuity reiterated a “buy” rating and set a $32.00 price target (down previously from $68.00) on shares of Envision Healthcare in a report on Thursday, November 2nd. Finally, SunTrust Banks set a $40.00 target price on shares of Envision Healthcare and gave the company a “buy” rating in a report on Thursday, December 21st. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $41.83.
Envision Healthcare (NYSE EVHC) opened at $36.69 on Tuesday. The company has a market cap of $4,460.00, a price-to-earnings ratio of -24.62, a PEG ratio of 0.95 and a beta of 0.57. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01. Envision Healthcare has a fifty-two week low of $23.77 and a fifty-two week high of $73.00.
COPYRIGHT VIOLATION NOTICE: “Envision Healthcare Co. (EVHC) Expected to Post Quarterly Sales of $1.97 Billion” was published by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/02/13/envision-healthcare-co-evhc-expected-to-post-quarterly-sales-of-1-97-billion-2.html.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.